Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2000, p. 4265-4274, Vol. 20, No. 12
Kennedy Institute of Rheumatology, Imperial College School
of Medicine, Hammersmith, London W6 8LH, United
Kingdom1; UCSF Cancer Center, San
Francisco, California 94143-02182; and
Department of Molecular Genetics and Microbiology, Robert
Wood Johnson Medical School, University of Medicine and
Dentistry
Received 24 January 2000/Returned for modification 6 March
2000/Accepted 20 March 2000
A tetracycline-regulated reporter system was used to investigate
the regulation of cyclooxygenase 2 (Cox-2) mRNA stability by the
mitogen-activated protein kinase (MAPK) p38 signaling cascade. The
stable
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Regulation of Cyclooxygenase 2 mRNA Stability by the
Mitogen-Activated Protein Kinase p38 Signaling Cascade
New Jersey, Piscataway, 088543 New
Jersey
-globin mRNA was rendered unstable by insertion of the
2,500-nucleotide Cox-2 3' untranslated region (3' UTR). The chimeric
transcript was stabilized by a constitutively active form of MAPK
kinase 6, an activator of p38. This stabilization was blocked by
SB203580, an inhibitor of p38, and by two different dominant negative
forms of MAPK-activated protein kinase 2 (MAPKAPK-2), a kinase lying
downstream of p38. Constitutively active MAPKAPK-2 was also able to
stabilize chimeric
-globin-Cox-2 transcripts. The MAPKAPK-2
substrate hsp27 may be involved in stabilization, as
-globin-Cox-2
transcripts were partially stabilized by phosphomimetic mutant forms of
hsp27. A short (123-nucleotide) fragment of the Cox-2 3' UTR was
necessary and sufficient for the regulation of mRNA stability by the
p38 cascade and interacted with a HeLa protein immunologically related
to AU-rich element/poly(U) binding factor 1.
*
Corresponding author. Mailing address: Kennedy
Institute of Rheumatology, Imperial College School of Medicine, 1 Aspenlea Rd., Hammersmith, London W6 8LH, United Kingdom. Phone: (0044) 181 383 4430. Fax: (0044) 181 383 4499. E-mail:
a.clark{at}cxwms.ac.uk.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|